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Abstract
Background—Embryonic Stem (ES) cells have been investigated as a potential replacement
therapy for failed organs, such as the liver. However, detection of hepatic engraftment from candidate
stem cells has been difficult due to low engraftment efficiency. Previous detection methods required
that the graft be processed by molecular and/or immunohistochemical techniques, limiting further
functional studies. This study evaluated the use of tri-dimensional (3-D) fluorescent
stereomicroscopy for gross detection of ES cell derived hepatic engraftment.
Material and methods—Murine ES cells expressing the enhanced green fluorescence protein
(EGFP) underwent directed endodermal lineage differentiation. Three days after 2/3rds partial
hepatectomy, cells were injected into the liver parenchyma, and livers were harvested at 10–20 days
and examined by fluorescence stereomicroscopy with a GFP2 long pass filter. The sensitivity and
reliability of the test was evaluated using quantitative PCR to assay for the presence of EGFP mRNA
in the tissue.
Results—Fluorescent microscopy detected EGFP-positive cells engrafted with normal histology
in 5 of 11 specimens. EGFP mRNA was confirmed in all five specimens by q-PCR. Only 1 of the
11 specimens was negative by fluorescence stereomicroscopy and positive by q-PCR, P < 0.02,
Fisher’s exact test.
Conclusion—Utilization of 3-D stereomicroscopy with a GFP2 long pass filter is a powerful and
fast screening tool for GFP-ES derived hepatic engraftment.
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INTRODUCTION
The insufficient availability of donor organs for liver transplantation has increased the
requirement for new alternative therapies for end stage liver disease. One of these potential
new therapies, cellular transplantation, is being intensively investigated and is based in part on
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the liver’s regenerative nature. Numerous animal studies have shown the ability of mature
hepatocytes to repopulate acutely damaged livers [1] [2] [3] and mature hepatocytes have been
used clinically with some success [4] [5]. However, these cells demonstrate significant
limitations, such as limited repopulation capability and allograft rejection [6]. Due to these
problems, other laboratories, including ours, have done studies with phenotypically defined
hepatic progenitors as candidates for cell transplantation [7-9]. Although the hepatic progenitor
appeared to be a good candidate due to its stem cell characteristics, it has been proven to be
difficult to isolate [7]. As an alternative, the use of embryonic stem (ES) cell derivatives is
particularly attractive, because of their ability to be expanded in culture, their plasticity
[10-12] and the subsequent potential to undergo directed differentiation under appropriate in
vitro conditions [13,14]. An additional theoretical advantage of ES cells is their expected
immune privilege [15].
While promising, the embryonic stem cell derivates have shown a low engraftment efficiency,
lack of function in the liver [16] [17], and even fusion of the injected cells to the surrounding
hepatocytes [18]. Therefore, a more direct approach based on the developmental relationship
between ES cells, definitive endoderm and hepatocellular function is required in order to
increase efficiency, function and safety of ES cell derivate transplants into the liver. Our lab
had recently shown that ES cells differentiate into putative endodermal precursors (PEPs) after
direct differentiation in vitro in the presence of acidic fibroblast growth factor (aFGF). We
have been able to deliver these PEPs into the liver parenchyma, resulting in high engraftment
efficiency, and we have also been able to show recovery of function in both a syngeneic and
allogeneic model in a Factor-IX (F-IX) Knockout (KO) murine model. In addition, we
performed genetic analysis on laser capture microdissected PEPs from the engrafted areas that
excluded cell fusion as the main engraftment mechanism [19].
There are still several open questions that need to be addressed regarding the efficiency and
safety issue. Multiple variables can be modified in vitro in order to affect the degree of ES cell
differentiation into the desired lineage pre- transplantation [20-22] that may also affect the
engraftment efficiency, liver regeneration and recovery of function. Additionally, some of
these modifications may also result in the decrease of spontaneous differentiation into
undesirable lineages and substantial reduction of the risk of teratoma formation [22,23]. The
ability to track the ultimate in vivo effect of the in vitro variables requires an accurate, high
throughput model in which the engraftment characteristics can be detected.
Previous studies of engraftment efficiency have used several molecular and
immunohistochemical methods including: flow cytometry [24-28], histological and
immunostaining techniques [28-30], b-gal staining analysis of whole liver and tissue sections
[31], different types of PCR analysis [32-35] and/or a combination of several of these methods
[36]. As the use of such methods has proven to be labor intensive and costly, we examined past
attempts at detection and evaluation of cellular structural function and liver sinusoidal
architecture to determine if similar strategies could be applied to our models. Most of these
characterizations have taken advantage of the use of different microscopy techniques to
evaluate structure and function [37-39]. In addition, 3-D microscopy has been successfully
applied to the detection of fluorescence cells in large specimens [40-42]. Thus, we have applied
this microscopy technique in a novel way to study engraftment levels in our model.
In this paper we describe an improved method for preliminary gross detection of engrafted
areas within the liver using genetically labeled fluorescent ES cells and 3-D fluorescent
stereomicroscopy. The use of stereomicroscopy has shown to be extremely useful and critical
in identifying samples that demonstrate positive engraftment and allows us to efficiently focus
on detailed characterization only on samples that show positivity [19].
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The murine ES cells, A129Bk4 (elf), express the enhanced GFP fused to a nuclear targeting
tag, driven by the b-actin promoter [13]. ES cells were propagated over fibroblast feeder layers
and differentiated in collagen plates in the presence of 100 ng/ml of aFGF as described
previously [19]. At 7 days post-differentiation, cells were harvested, re-suspended at 1×104
cells/μl in 1% FBS-PBS, and injected into mice.
Animal Model
A total of 11 males, ages 8 to 16 -week-old BALB/c, C57BL/6 and F-IX deficient mice were
used in this study. Wild types were obtained from the Jackson Laboratories (Bar Harbor, ME)
and F-IX knockouts from Dr. Darrell Stafford of the Department of Biology (University of
North Carolina at Chapel Hill, NC). Animals were maintained in a controlled environment and
the facility is managed by the Division of Laboratory Animal Management (DLAM), Chapel
Hill, NC.
Surgical Procedures
All surgical procedures were performed in accordance with protocols approved by the Institute
of Animal Care and Use Committee (IACUC). Mice were subjected to 2/3rds partial
hepatectomy as described by Higgins and Anderson [43] under anesthesia (60mg/kg ketamine;
6 mg/kg xylazene). Two days after partial hepatectomy, 100 μl of differentiated ES cells were
injected into the liver parenchyma at a density of 104cells/μl. The ES cell dose was chosen
based on previously published data for hepatocyte transplantation (revised on [44]) To perform
the partial hepatectomy on the F-IX KO mice, the mice were given 100 units/kg recombinant
human F-IX (from the laboratory of Dr. Stafford) [45], both by intramuscular and subcutaneous
injection after anesthesia, and another dose 4 hours (h) after the operation. At the time when
the GFP-PEP injections were performed on postoperative day 3, the intramuscular and
subcutaneous doses of human F-IX were repeated. Recombinant human F-IX (stock
concentration: 575 μg/ml) was used.
Fluorescent Stereomicroscopy
In order to identify the engraftment, mice were sacrificed 10 to 20 days after transplantation
and the liver was harvested. Fresh liver samples were then examined with a stereomicroscope
(MZ16FA; Leica Microsystems AG, Wetzlar, Germany) with the GFP2 long pass filter
(100447084, Leica Microsystems AG, Wetzlar, Germany) for the presence of GFP positive
cells.
Histological Analysis
To further characterize cell engraftment, liver tissue samples were washed in phosphate buffer
(PBS), fixed overnight in 4% paraformaldehyde and processed for cryosectioning [19]. Tissue
samples were analyzed by standard fluorescent microscopy (Axiovert S100; Carl Zeiss
MicroImaging, Inc., Thornwood, NY).
Immunofluorescence
Slides with tissue cryosections processed as above were washed twice in PBS, permeabilized,
and blocked against nonspecific binding in blocking buffer (5% normal serum/2% BSA/0.1%
Triton X-100 in PBS) for 30 minutes (min). Samples were then incubated with sheep anti-rat
F-IX antibody (Haematologic Technologies, Essex Junction, VT) for 90 min at room
temperature at a final dilution of 1:200 in blocking buffer. After the incubation, samples were
washed three times with PBS-0.05% Triton X-100, followed by incubation with Texas red-
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labeled anti-sheep IG (Fab’2) IgG (Jackson ImmunoResearch Laboratories, West Grove, PA)
diluted 1:200 in blocking buffer for 30 min. After three washings in PBS-0.1% Triton X-100,
samples were incubated with rabbit polyclonal GFP antibody conjugated to Alexa Fluor 488
(Molecular Probes) for 1 h at room temperature (1:400 dilution in blocking buffer). After three
washings with PBS-0.1% Triton X-100, they were mounted with Vectashield mounting media
(Vector Laboratories). This last procedure was also used for the samples that were only
incubated with anti –GFP antibody conjugated to Alexa Fluor 488. Processed slides were
examined under a Zeiss Axiovert S100 fluorescent microscope, and representative slides were
further analyzed by a confocal laser-scanning microscopy performed on a Zeiss LSM5 Pascal
microscope (Thornwood, NY).
PCR Analysis
Quantitative RT-PCR analysis was used to confirm the presence of GFP mRNA. The cDNA
was synthesized by oligo-dT priming and subjected to PCR amplification with primer sets for
EGFP and b-actin for internal control. PCR was performed in a total reaction volume of 50
μl consisting of 1 μM each primer, 200 μM dNTP, 50 mM KCl, 1.5 MM MgCl2, 10 MM Tris
HCl, pH 8.3 and 1.2 U Amplitaq polymerase (Cetus Corporation, Berkeley, CA). Samples
were denatured at 94°C for 3 min followed by 30 amplification cycles (1 min at 94 °C, 1 min
at 62°C and 2 min at 72 °C) and a final extension at 72 °C for 5 min. Samples were analyzed
in 2% agarose gel in Tris/Acetate/EDTA buffer and visualized with ethidium bromide. The
primers used for EGFP detection by RT-PCR were: 5’aca aca gcc aca acg tct ata as forward
primer and 5’gtg gcg gat ctt gaa gtt ca as the reverse primer.
Statistical Analysis
Data was obtained from direct observation under the 3-D microscope and compared to the RT-
PCR. The Fisher’s exact test was used for statistical analysis.
RESULTS
The 11 mice, 6 transplanted with PEPs and 5 non-transplanted controls, were sacrificed
between days 10 to 20 after ES derived cells were injected into the liver parenchyma of
experimental models and the livers were harvested for examination by fluorescent
stereomicroscopy and qRT-PCR analysis. Fresh livers were analyzed by 3-D fluorescent
stereomicroscopic observation and positive fluorescent cells were detected in 5 of the 6 samples
from the transplanted mice. Fluorescence above the general background was not detected in
one of the samples from the transplanted mice or in any of the five control samples. In Figure
1 representative results from one of the samples analyzed 10 days post injection are shown.
Clear fluorescent patches can be readily detected in the liver surface (a, b). At higher
magnification the fluorescent patches can be identified as clusters of GFP positive cells (c, d)
embedded in the liver parenchyma. Representative histological studies of this same sample are
shown in Figure 2. ES derived cell engraftment can be detected and identified in the tissue
section by the nuclear localization of the GFP.
To confirm the presence of GFP and further characterize the engrafted cells’ morphology
within the liver architecture, representative tissue samples were analyzed by
immunofluorescence techniques using a specific GFP antibody. As it is shown in Figure 3, this
study demonstrates the presence of GFP positive cells with different morphological
characteristics embedded in the liver parenchyma. Both cells exhibit a clear distinct
morphology (a, b) and cells similar to the surrounding cells, can be detected in the engrafted
areas (c, d).
Caballero et al. Page 4













As part of the engrafted cells’ characterization, liver samples from F-IX KO injected mice were
analyzed by stereomicroscopy and positive areas were subjected to immunofluorescence
characterization using both anti-FIX and anti-GFP antibody. Figure 4 shows a representative
picture demonstrating that the GFP + cell (b) and F-IX (c) cell are in the same engrafted area.
The overlay image (d) showing co-localization seems to indicate that some of the cells may
have became hepatocytes, as only hepatocytes have been described to produce F-IX.
In order to evaluate the sensitivity and reliability of the gross detection by fluorescent
stereomicroscopy, we analyzed tissue samples from the fresh liver for the presence of GFP
mRNA by qRT-PCR. Although only 5 out of 6 samples from transplanted mice were positive
by fluorescence and all of them were positive for GFP when assayed by qRT-PCR. The other
5 control samples that were fluorescence negative were also negative by qRT-PCR (Table 1).
DISCUSSION
We have previously used different techniques for the analysis of engraftment efficiency,
including: flow cytometry, PCR and histological analysis. All of them have significant time
and cost issues as our research requires the analysis of a large number of samples from each
individual mouse of which only a small percentage demonstrated positive engraftment. Thus,
we have created an innovative, cost-effective, and time-saving method for preliminary gross
detection of engrafted areas within the liver.
A fluorescent stereomicroscope equipped with GFP filter allows for direct observation of
fluorescence without any tissue treatment. In this study clusters of engrafted cells in the surface
of the liver are easily detectable. Use of the appropriate observation filters, such as the GFP2
long pass filter together with the nuclear localization of the GFP, generates an image that easily
discriminates between real positive engraftment and the general autofluorescence produced by
the liver. These observations were validated by a good correlation between the observation of
fluorescence and detection of GFP positive cells by qRT-PCR and histological analysis.
As described in the Results section, the technique identified positive engraftment in 5 out of
the 6 samples obtained from transplanted animals; all of them tested positive for engraftment
when analyzed by RT-PCR. As we do not have the engraftment efficiency in those samples,
we do not know if the fluorescence-negative samples had only a very small limited engraftment
that could only be detected by a more sensitive technique such as PCR (Table 1); Alternatively
the engrafted area could have been located more internally and would not be accessible to the
penetration range of the stereomicroscope. Although the sensitivity of the technique is 83%
while the PCR is 100%, the specificity is 100% with no fluorescence detected in any of the
negative control samples. We can therefore conclude that the utilization of 3-D fluorescent
stereomicroscopy provides a fast, sensitive and reliable tool to define which sample tissues
have engrafted.
In addition, identification by stereomicroscopy of these specific engrafted areas within the liver
sample is crucial for characterization by immunostaining. Stereomicroscopy demonstrated that
GPF positive engrafted cells acquire hepatic morphology and are able to synthesize F-IX in
our hemophilic mouse models. We were also able to retrieve GFP positive cells from the best
engrafted areas by LCM for genetic analysis. The results of the genomic DNA contribution
analysis show no detectable co-localization of wild type DNA with GFP DNA in the
fluorescence positive areas of the liver parenchyma, thus excluding cell fusion as the main
engraftment mechanism in our models [19]. The use of 3-D microscopy has also been an
important tool for characterization of the liver parenchyma, with special interest in areas of
positive engraftment that showed the presence of ES derived cells with different morphologies.
These morphologies may correspond with different cellular states. Alternately, the large cells
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with distinct morphology may represent cell types other than those derived from the endoderm
or cells that are not able to integrate within the tissue and demonstrate senescence with time.
On the contrary, GPF+ cells in other engrafted areas with morphology similar to that of the
surrounding hepatocytes could be observed. Some of those ES derived cells are able to function
as hepatocytes as indicated by the presence of F-IX, co-localizing with GFP+ cells in the
transplanted F-IX KO mice liver samples. The histological characterization of positive
engrafted areas also showed no morphological evidence of immunological rejection.
As a further step to expand the relevance of the engraftment evaluation by fluorescence
stereomicroscopy, our laboratory is currently using this technique to compare the effect of
different surgical procedures on the ES cells engraftment efficiency. Quantitative analysis of
engraftment efficiency by PCR is studied in parallel with qualitative analysis of engraftment
localization analyzed by fluorescence stereomicroscopy, as described in this publication.
In conclusion, the present study revealed that scanning the sample by fluorescence
stereomicroscopy is a powerful and reliable tool for fast screening of EGFP-ES derived hepatic
engraftment areas in the liver of transplanted mice. The use of this technique in detecting
positive engraftment showed that PEPs are able to engraft in the liver parenchyma without
fusion to the surrounding hepatocytes and that they acquire both hepatic morphology and
function shown by the production of F-IX. This study has been made in both syngeneic and
allogeneic models without any evidence of rejection and has been reported in Proceedings of
the National Academy of Sciences [19].
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Fluorescence stereomicroscopic analysis of liver samples. .Representative images of engrafted
areas on freshly dissected liver samples at 10 days post injection. Fluorescence patches can be
detected at low magnification (a, b); higher magnification shows that these patches are formed
by clusters of GFP positive cells (c, d).
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Histological analysis of fluorescence patches. After dissection of fluorescent areas under
fluorescence stereomicroscopic observation, the tissue was cryosectioned and subjected to (a)
light and (b) fluorescence microscopic observation. The engrafted cells can be readily
identified by the nuclear localization of the GFP.
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Immunofluorescence analysis of fluorescent positive areas. Fluorescent positive areas were
cryosectioned, immunostained with anti-GFP antibody and fluorescence was analyzed by
confocal microscopy, (a, c) fluorescence, (b, d) overlay with light analysis image. Antibody
specific staining allows the identification of cells that lost their fluorescence during the
cryosectioning procedure.
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Immunofluorescence analysis of Factor IX production. Fluorescent positive areas were
cryosectioned and co-immunostained for GFP (green) and Factor IX (red). Images were
analyzed by confocal microscopy. (a) Light image, (back) fluorescent images, (d) overlay. Co-
staining allows for identification of specific cells that may be producing factor IX (co
localization of GFP+ cells with F-IX, yellow).
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TABLE 1
Fluorescence Stereomicroscopy as Screening Tool.
Transplanted Non-Transplanted
Fluorescence + 5 0
Fluorescence - 1 5
PCR + 6 0
PCR - 0 5
Total 6 5
p=0.02, Fisher exact test
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